Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPhio Pharmaceuticals Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$1.54 | $0 | |||
| 08/14/2024 | Q2 2024 | -$3.62 | $0 | |||
| 05/09/2024 | Q1 2024 | -$4.24 | $0 | |||
| 04/01/2024 | Q4 2023 | -$4.56 | $30,000 | |||
| 11/09/2023 | Q3 2023 | -$10.26 | $0 | |||
| 08/10/2023 | Q2 2023 | -$13.29 | $0 | |||
| 05/11/2023 | Q1 2023 | -$28.41 | $0 | |||
| 03/22/2023 | Q4 2022 | -$20.52 | $0 | |||
| 11/10/2022 | Q3 2022 | -$28.33 | $0 | |||
| 08/11/2022 | Q2 2022 | -$20.11 | $0 | |||
| 05/12/2022 | Q1 2022 | -$21.07 | $0 | |||
| 03/22/2022 | Q4 2021 | -$27.57 | $0 | |||
| 11/10/2021 | Q3 2021 | -$29.89 | $0 | |||
| 08/12/2021 | Q2 2021 | -$21.46 | $0 | |||
| 05/13/2021 | Q1 2021 | -$34.49 | $0 | |||
| 03/25/2021 | Q4 2020 | -$46.05 | $0 | |||
| 11/10/2020 | Q3 2020 | -$43.18 | $0 | |||
| 08/12/2020 | Q2 2020 | -$0.64 | -$36.40 | -35.76 | $0 | |
| 05/12/2020 | Q1 2020 | -$93.67 | $0 | |||
| 03/26/2020 | Q4 2019 | -$507.38 | $0 |
Phio Pharmaceuticals Corp. Earnings: FAQ's
Did Phio Pharmaceuticals Corp. beat their earnings estimates last
quarter?
In the previous quarter, Phio Pharmaceuticals Corp. (:PHIOW) reported $-0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64 by $0.3.
How can I listen to Phio Pharmaceuticals Corp.'s earnings conference
call?
The conference call for Phio Pharmaceuticals Corp.'s latest earnings report can be listened to online.
How can I read Phio Pharmaceuticals Corp.'s conference call transcript?
The conference call transcript for Phio Pharmaceuticals Corp.'s latest earnings report can be read online.
How much profit does Phio Pharmaceuticals Corp. generate each year?
Phio Pharmaceuticals Corp. (:PHIOW) has a recorded net income of $0. Phio Pharmaceuticals Corp. has generated $-46.87 earnings per share over the last four quarters.
What is Phio Pharmaceuticals Corp.'s price-to-earnings ratio?
Phio Pharmaceuticals Corp. (:PHIOW) has a price-to-earnings ratio of -0.48 and price/earnings-to-growth ratio is -0.01.